Psychotherapeutic & Neurological Drugs account for less than one-third of one percent of all prescriptions dispensed to California injured workers but due to their high average cost per prescription ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

At an Institute for Value-Based Medicine® event held in Aurora, Colorado, experts discussed strategies to improve patient outcomes and manage health care costs in neurological diseases. Am J Manag ...

Neurology has seen a surge in drug options, necessitating comparative effectiveness research to guide treatment decisions and address disparities in access and outcomes. Collaborative efforts between ...

Researchers will join a new NIH-supported network working to develop novel approach methodologies that complement or replace ...

July 24 (Reuters) - Biogen (BIIB.O), opens new tab and Sage Therapeutics (SAGE.O), opens new tab do not plan to conduct further studies for their neurological disorder drug after it failed in a ...

They say one man’s trash is another man’s treasure, or in this case, therapeutic, as a pioneering method turns waste plastic ...

Scientists engineered the first fully synthetic brain tissue model. It’s fully functional brain tissue that they can use to test neurological drugs. They believe the discovery will lead them to better ...

Add Yahoo as a preferred source to see more of our stories on Google. Psychedelics have a long and rich history in human culture, with archaeologists estimating that humans first started consuming ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration shows Biogen logo (Reuters) -Biogen and Sage Therapeutics do not plan to conduct further studies for their ...